Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131 I-NaI treatments of differentiated thyroid cancer. (Q50943856)

3 June 2018

title

Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131 I-NaI treatments of differentiated thyroid cancer. (English)

1 reference

3 June 2018

Katarina Sjögreen Gleisner

author

6

1 reference

http://europepmc.org/abstract/MED/27782699

30 March 2018

Glenn D Flux

object named as

Glenn Flux

2

0 references

author name string

Pablo Mínguez

1

1 reference

3 June 2018

José Genollá

3

1 reference

3 June 2018

Alejandro Delgado

4

1 reference

3 June 2018

Emilia Rodeño

5

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 October 2016

1 reference

3 June 2018

published in

Medical Physics

1 reference

3 June 2018

volume

43

1 reference

3 June 2018

issue

10

1 reference

3 June 2018

page(s)

5279-5287

1 reference

3 June 2018

The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0

cites work

1 reference

A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer

21 January 2018

1 reference

Strategies of radioiodine ablation in patients with low-risk thyroid cancer.

21 January 2018

1 reference

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

21 January 2018

1 reference

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

21 January 2018

1 reference

To ablate or not to ablate: issues and evidence involved in 131I ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma

21 January 2018

1 reference

Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET.

21 January 2018

1 reference

A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer.

21 January 2018

1 reference

Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients. Dosimetry-based model for estimation

21 January 2018

1 reference

Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct Monte Carlo methods.

21 January 2018

1 reference

Usefulness of 99mTc-pertechnetate single-photon emission computed tomography in remnant mass estimation of postsurgical patients of differentiated thyroid cancer during internal dosimetry

21 January 2018

1 reference

Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration

21 January 2018

1 reference

Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial

21 January 2018

1 reference

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

21 January 2018

1 reference

Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations

21 January 2018

1 reference

The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

21 January 2018

1 reference

Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms

21 January 2018

1 reference

Risk of second primary cancer following differentiated thyroid cancer.

21 January 2018

1 reference

Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.

21 January 2018

1 reference

Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease

21 January 2018

1 reference

Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma.

21 January 2018

1 reference

Thyroid stunning: fact or fiction?

21 January 2018

1 reference

Statistical and radiobiological analysis of the so-called thyroid stunning

21 January 2018

1 reference

Guidelines for radioiodine therapy of differentiated thyroid cancer

21 January 2018

1 reference

A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions

21 January 2018

1 reference

Down-regulation of the Sodium/Iodide Symporter Explains 131I-Induced Thyroid Stunning

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1118/1.4961742

1 reference

3 June 2018

PubMed ID

28105713

1 reference

3 June 2018